Home › Funds › NWI MANAGEMENT LP › ALLO
NWI MANAGEMENT LP position in ALLO
ALLOGENE THERAPEUTICS INC · Health Care
NWI MANAGEMENT LP reported holding 100,000 shares of ALLO (ALLOGENE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$208K, representing 0.01% of its reported portfolio and ranking #50 among its reported holdings. NWI MANAGEMENT LP has disclosed ALLO holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How NWI MANAGEMENT LP's ALLO position evolved
NWI MANAGEMENT LP first disclosed a stake in ALLO in Q2 2025 at 100,000 shares (US$113K). The position peaked in Q1 2026 at 100,000 shares, worth US$244K. Across 5 filings, NWI MANAGEMENT LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 100,000 shares valued at US$208K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 100.00K | $113.00K | New |
| Q3 2025 | 100.00K | $124.00K | Hold |
| Q4 2025 | 100.00K | $137.00K | Hold |
| Q1 2026 | 100.00K | $244.00K | Hold |
| Q2 2026 | 100.00K | $208.00K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALLO and 13F data
ALLO (ALLOGENE THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in ALLO — the largest reported positions include PFIZER INC (US$46.9M), Frazier Life Sciences Management, L.P. (US$46.7M), TPG GP A, LLC (US$38.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALLO
- PFIZER INC 22.03M sh · $46.93M · Q2 2026
- Frazier Life Sciences Management, L.P. 22.45M sh · $46.69M · Q2 2026
- TPG GP A, LLC 18.72M sh · $38.93M · Q2 2026
- Sio Capital Management, LLC 13.32M sh · $27.71M · Q2 2026
- GordonMD Global Investments LP 5.30M sh · $11.02M · Q2 2026
- Patient Square Capital LP 5.05M sh · $10.50M · Q2 2026
- Wildcat Capital Management, LLC 2.92M sh · $6.08M · Q2 2026
- DAFNA Capital Management LLC 2.00M sh · $4.16M · Q2 2026
More on NWI MANAGEMENT LP
FAQ
How long has NWI MANAGEMENT LP held ALLO?
NWI MANAGEMENT LP has disclosed ALLO holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is NWI MANAGEMENT LP's current position in ALLO?
As of Q2 2026, NWI MANAGEMENT LP holds 100.00K shares of ALLO (ALLOGENE THERAPEUTICS INC), valued at $208.00K, representing 0.01% of its reported portfolio and ranking #50.
Has NWI MANAGEMENT LP been buying or selling ALLO?
In the latest 13F filing (Q2 2026), NWI MANAGEMENT LP held unchanged its position in ALLO. The position peaked in Q1 2026 at 100.00K shares.
Which other funds hold ALLO?
Other major institutional holders of ALLO include PFIZER INC, Frazier Life Sciences Management, L.P., TPG GP A, LLC, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.